Business description
bioMérieux S.A. is one of the world leaders in the field of in vitro diagnostics for over 50 years. bioMérieux is present in more than 160 countries through 42 subsidiaries and a large network of distributors. bioMérieux provides diagnostic solutions (reagents, instruments, software and services) which determine the source of disease and contamination to improve patient health and ensure product safety. In clinical applications, the Company offers a wide range of solutions for managing infectious diseases, cardiovascular diseases and targeted cancers. For the agri-food, cosmetics and pharmaceutical industries, bioMérieux provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing.
Management board & Supervisory board
| CEO |
| Jean-Luc Belingard |
| Management board |
| Henri Thomasson, Alain Pluquet, Alexandre Mérieux, François Lacoste, Jean-Marc Durano, Marc Mackowiak, Michel Baguenault, Stefan Willemsen, Steve Harbin, Thierry Bernard |
| Supervisory board |
| Alexandre Mérieux, Agnès Lemarchand, Alain Mérieux, arie-Hélène Habert-Dassault, Fanny Letier, Frédéric Besème, Harold Boël, Jean-Luc Bélingard, Marie-Paul Kieny, Philippe Archinard |
Company data
| Name: |
bioMerieux S.A. |
| Address: |
Chemin de l'Orme,F-69280 Marcy l'Etoile |
| Phone: |
+33-4-7887-2000 |
| Fax: |
+33-4-7887-2090 |
| E-mail: |
-
|
| Internet: |
www.biomerieux.com |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
33.97% |
| IPO date: |
- |